drugset / Trial / NCT04740970
A Study of JNJ-64304500 in Participants With Alopecia Areata
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the clinical response of 22 weeks of study intervention with JNJ-64304500, compared with placebo, in participants with moderate to severe alopecia areata (AA).
Timeline
- Start
- 2021-03-24
- Primary completion
- 2022-06-02
- Completion
- 2022-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-64304500 | Unknown | — | Subcutaneous |